Literature DB >> 35450370

Selective Serotonin Receptor Modulators for Use in the Treatment of Psychological Disorders.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2022        PMID： 35450370      PMCID： PMC9014713          DOI： 10.1021/acsmedchemlett.2c00110

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Anti-inflammatory activity of ayahuasca: therapeutical implications in neurological and psychiatric diseases.

Authors:  Marina Goulart da Silva; Guilherme Cabreira Daros; Rafael Mariano de Bitencourt
Journal:  Behav Brain Res       Date:  2020-11-06       Impact factor: 3.332

2.  Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery.

Authors:  Samuel Obeng; Takato Hiranita; Francisco León; Lance R McMahon; Christopher R McCurdy
Journal:  J Med Chem       Date:  2021-05-06       Impact factor: 7.446

3.  Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.

Authors:  Danilo De Gregorio; Argel Aguilar-Valles; Katrin H Preller; Boris Dov Heifets; Meghan Hibicke; Jennifer Mitchell; Gabriella Gobbi
Journal:  J Neurosci       Date:  2020-11-30       Impact factor: 6.167

4.  Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma.

Authors:  Emma Eckernäs; Adam Bendrioua; Chiara Cancellerini; Christopher Timmermann; Robin Carhart-Harris; Kurt-Jürgen Hoffmann; Michael Ashton
Journal:  J Pharm Biomed Anal       Date:  2022-02-03       Impact factor: 3.935

Review 5.  Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects.

Authors:  Jacob S Aday; Alan K Davis; Cayla M Mitzkovitz; Emily K Bloesch; Christopher C Davoli
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-05

Review 6.  A narrative synthesis of research with 5-MeO-DMT.

Authors:  Anna O Ermakova; Fiona Dunbar; James Rucker; Matthew W Johnson
Journal:  J Psychopharmacol       Date:  2021-10-19       Impact factor: 4.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.